Dilation Capital Management LP Acquires 8,605 Shares of The Sherwin-Williams Company $SHW

Dilation Capital Management LP increased its holdings in The Sherwin-Williams Company (NYSE:SHW) by 60.9% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 22,746 shares of the specialty chemicals company’s stock after buying an additional 8,605 shares during the quarter. Sherwin-Williams comprises approximately 3.9% of Dilation Capital Management LP’s portfolio, making the stock its 12th biggest position. Dilation Capital Management LP’s holdings in Sherwin-Williams were worth $7,876,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of SHW. Richard W. Paul & Associates LLC grew its stake in shares of Sherwin-Williams by 1.6% in the second quarter. Richard W. Paul & Associates LLC now owns 1,885 shares of the specialty chemicals company’s stock worth $647,000 after acquiring an additional 30 shares during the period. Valley Brook Capital Group Inc. boosted its holdings in Sherwin-Williams by 2.4% in the second quarter. Valley Brook Capital Group Inc. now owns 1,311 shares of the specialty chemicals company’s stock worth $450,000 after purchasing an additional 31 shares during the last quarter. 17 Capital Partners LLC grew its position in Sherwin-Williams by 0.9% in the 2nd quarter. 17 Capital Partners LLC now owns 3,340 shares of the specialty chemicals company’s stock worth $1,147,000 after purchasing an additional 31 shares during the period. Alpine Bank Wealth Management raised its stake in Sherwin-Williams by 4.1% during the 3rd quarter. Alpine Bank Wealth Management now owns 781 shares of the specialty chemicals company’s stock valued at $270,000 after buying an additional 31 shares during the last quarter. Finally, Jessup Wealth Management Inc lifted its holdings in shares of Sherwin-Williams by 1.4% during the 2nd quarter. Jessup Wealth Management Inc now owns 2,341 shares of the specialty chemicals company’s stock valued at $804,000 after buying an additional 32 shares during the period. Institutional investors own 77.67% of the company’s stock.

Sherwin-Williams Stock Up 2.7%

SHW opened at $356.35 on Thursday. The stock has a market cap of $88.34 billion, a price-to-earnings ratio of 34.77, a price-to-earnings-growth ratio of 4.28 and a beta of 1.26. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.52 and a current ratio of 0.82. The firm’s fifty day moving average is $335.42 and its 200 day moving average is $343.67. The Sherwin-Williams Company has a fifty-two week low of $308.84 and a fifty-two week high of $379.65.

Sherwin-Williams (NYSE:SHW) last issued its quarterly earnings results on Tuesday, October 28th. The specialty chemicals company reported $3.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.44 by $0.15. Sherwin-Williams had a return on equity of 66.75% and a net margin of 11.05%.The business had revenue of $6.36 billion during the quarter, compared to analyst estimates of $6.21 billion. During the same quarter in the prior year, the business posted $3.37 EPS. Sherwin-Williams’s revenue for the quarter was up 3.2% compared to the same quarter last year. Sherwin-Williams has set its FY 2025 guidance at 11.250-11.450 EPS. On average, sell-side analysts forecast that The Sherwin-Williams Company will post 12 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

SHW has been the subject of several research analyst reports. Bank of America cut their price objective on Sherwin-Williams from $375.00 to $368.00 and set a “neutral” rating for the company in a report on Tuesday, October 14th. Vertical Research upgraded Sherwin-Williams from a “hold” rating to a “buy” rating and set a $371.00 price target for the company in a research note on Wednesday, January 7th. JPMorgan Chase & Co. increased their price objective on shares of Sherwin-Williams from $378.00 to $385.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Royal Bank Of Canada set a $405.00 price objective on shares of Sherwin-Williams and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Finally, UBS Group reaffirmed a “buy” rating and set a $415.00 target price (down from $422.00) on shares of Sherwin-Williams in a report on Monday, January 12th. Twelve equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $388.44.

Sherwin-Williams Company Profile

Sherwin-Williams (NYSE: SHW) is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.

The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.